Teligent Revenue 2010-2021 | TLGT

Teligent revenue from 2010 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Teligent Annual Revenue
(Millions of US $)
2020 $45
2019 $66
2018 $66
2017 $60
2016 $63
2015 $44
2014 $34
2013 $18
2012 $9
2011 $8
2010 $6
2009 $4
Teligent Quarterly Revenue
(Millions of US $)
2021-06-30 $10
2021-03-31 $12
2020-12-31 $10
2020-09-30 $14
2020-06-30 $14
2020-03-31 $7
2019-12-31 $16
2019-09-30 $18
2019-06-30 $18
2019-03-31 $13
2018-12-31 $17
2018-09-30 $18
2018-06-30 $16
2018-03-31 $15
2017-12-31 $11
2017-09-30 $11
2017-06-30 $18
2017-03-31 $20
2016-12-31 $14
2016-09-30 $16
2016-06-30 $17
2016-03-31 $16
2015-12-31 $13
2015-09-30 $12
2015-06-30 $9
2015-03-31 $11
2014-12-31 $14
2014-09-30 $7
2014-06-30 $6
2014-03-31 $7
2013-12-31 $7
2013-09-30 $4
2013-06-30 $4
2013-03-31 $4
2012-12-31 $2
2012-09-30 $2
2012-06-30 $2
2012-03-31 $2
2011-12-31 $2
2011-09-30 $2
2011-06-30 $2
2011-03-31 $2
2010-12-31 $2
2010-09-30 $2
2010-06-30 $2
2010-03-31 $1
2009-12-31 $1
2009-09-30 $1
2009-06-30 $1
2009-03-31 $1
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Bausch Health Cos (BHC) Canada $3.597B 2.61
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00